A popular marketer of handheld ultrasound devices has won FDA approval for an AI-enabled B-line quantification tool for use with patients suspected of having compromised lung function.

Radiology AI vendor Bot Image may market its prostate software not only for diagnosing cancer when suspected but also for performing prostate screenings.

Big Tech players have been investing in partnerships with large healthcare providers on AI endeavors for several years now. According to both sides in one such collaboration, the resulting synergy offers “immense potential” to improve patient access, care and outcomes.

AI clinical decision support was particularly popular among younger radiologists, experts wrote in Scientific Reports. 

Registered nurses, NPs and EMTs bolstered the quality of their scans with the help of deep learning-based guidance.

When used to flag anomalies in combined chest and musculoskeletal X-rays, imaging AI can relieve overstretched emergency radiology teams.

The FDA has OK’d a new artificial intelligence platform for quickly diagnosing stroke on unenhanced CT scans.

Using CT scans, a deep learning algorithm can recommend optimal lung cancer screening intervals by distinguishing between high-risk and low-risk lung nodules.